Advance Praise Dr. Kankanala's combination of international research and personal insight has added significantly to the understanding of genetic patent practice. His comprehensive explanation of Indian, European and U.S. practice makes the book extremely useful for patent attorneys and corporate planners alike. The comparative analysis provides important clarity to the business strategy behind genetic innovation. JON M. GARON, Dean and Professor of Law, Hamline University School of Law The pathbreaking research on genes heralding the enhanced utility of genetic products raises questions of access and use. While the ultimate beneficiaries desire unmitigated access, the researchers seek safeguard against misappropriation. The book addresses this issue through a focused debate on the patent law system in US, European Union and India enabling propertisation of gene based inventions, how variation in threshold levels keep swinging the utility of genetic material between private domain and public domain. The scholarly discussion with supporting jurisprudence developed through case laws in the three patent jurisdiction in the book takes the reader through an interesting, thought provoking journey into the world of genetics and patent law interface. This book is useful to Researchers in genetics, Patent Attorneys, Patent Agents, IP teachers and all biotechnology companies. PROF. (DR.) T. RAMAKRISHNA, Professor of Law (IPR Chair), National Law School of India University, Bangalore A complex subject tackled brilliantly by Dr. Kankanala. While ensuring that the depth of subject matter is not compromised, Kalyan writes in a succinct and clear style. A must read for anyone involved in the biotechnology industry. Well referenced and comprehensive. SUDHIR BORGONHA, CEO, Clintest International Kalyan Kankanala's book is an outstanding contribution to the literature on genetic patent law and business strategy. It has rich analysis of cases and the underlying theories. The book is extremely useful to patent lawyers, business students and scholars and managers in the technology sector. PROF. MURALI PATIBANDLA, Indian Institute of Management, Bangalore Dr. Kankanala's work is a very readable and lucid gem of a book, even though it deals with subject matter that is scientifically, legally and culturally very complex and controversial. It is a comprehensive comparative overview, highlighting differences and difficulties encountered in genetic patent practice and strategy in the United Sates, Europe and India. By reference to his original "Patent Filter" model and "Comparative Analysis" chart as well on the applicable statutory and decisional laws and guidelines, he elucidates the patent ability of genetically modified (uni- and multicellular) organisms, genes, gene therapy and human beings. Furthermore, his extensive list of guiding principles and many hypothetical cases as well as his discussion of ever-present issues of ethics and morality are very helpful in assessing the business advantages and disadvantages derivable from the divergent laws and policies. KARL F. JORDA,PROFESSOR of Intellectual Property,Franklin Pierce Law Center, USA. This book was a great read. I loved Kalyan's no-nonsense tell-it-like-it-is style - no fluff or touch-feely. This is undoubtedly a very comprehensive reference source, which can be widely used by researchers, industrialists, lawyers, knowledge economists and others who are interested in the information business of biotechnology. The book contains lots of valuable and helpful information and is a great resource. This book is a great IP primer - I was pleasantly surprised by the depth and the Patent filter model. Give it a read! ANINDYA SIRCAR,Head of IP, Biocon India Private Limited.